Literature DB >> 20805844

Physiological levels of ATP negatively regulate proteasome function.

Hongbiao Huang1, Xiaoyan Zhang, Shujue Li, Ningning Liu, Wen Lian, Emily McDowell, Ping Zhou, Canguo Zhao, Haiping Guo, Change Zhang, Changshan Yang, Guangmei Wen, Xiaoxian Dong, Li Lu, Ningfang Ma, Weihua Dong, Q Ping Dou, Xuejun Wang, Jinbao Liu.   

Abstract

Intracellular protein degradation by the ubiquitin-proteasome system is ATP dependent, and the optimal ATP concentration to activate proteasome function in vitro is ∼100 μM. Intracellular ATP levels are generally in the low millimolar range, but ATP at a level within this range was shown to inhibit proteasome peptidase activities in vitro. Here, we report new evidence that supports a hypothesis that intracellular ATP at the physiological levels bidirectionally regulates 26S proteasome proteolytic function in the cell. First, we confirmed that ATP exerted bidirectional regulation on the 26S proteasome in vitro, with the optimal ATP concentration (between 50 and 100 μM) stimulating proteasome chymotrypsin-like activities. Second, we found that manipulating intracellular ATP levels also led to bidirectional changes in the levels of proteasome-specific protein substrates in cultured cells. Finally, measures to increase intracellular ATP enhanced, while decreasing intracellular ATP attenuated the ability of proteasome inhibition to induce cell death. These data strongly suggest that endogenous ATP within the physiological concentration range can exert a negative impact on proteasome activities, allowing the cell to rapidly upregulate proteasome activity on ATP reduction under stress conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20805844      PMCID: PMC2996470          DOI: 10.1038/cr.2010.123

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  43 in total

Review 1.  Degradation of oxidized proteins by the 20S proteasome.

Authors:  K J Davies
Journal:  Biochimie       Date:  2001 Mar-Apr       Impact factor: 4.079

2.  In vivo pH and metabolite changes during a single contraction in rat uterine smooth muscle.

Authors:  J Larcombe-McDouall; N Buttell; N Harrison; S Wray
Journal:  J Physiol       Date:  1999-08-01       Impact factor: 5.182

3.  Inhibition of rat liver transglutaminase by nucleotides.

Authors:  S Kawashima
Journal:  Experientia       Date:  1991-07-15

Review 4.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 5.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway.

Authors:  W E Mitch; A L Goldberg
Journal:  N Engl J Med       Date:  1996-12-19       Impact factor: 91.245

6.  Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: an in vivo 31P magnetic resonance spectroscopy study.

Authors:  Susanne Leij-Halfwerk; Hendrik J Agteresch; Paul E Sijens; Pieter C Dagnelie
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

7.  Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations.

Authors:  Saul R Powell; Kelvin J A Davies; Andras Divald
Journal:  J Mol Cell Cardiol       Date:  2006-11-30       Impact factor: 5.000

Review 8.  Getting to first base in proteasome assembly.

Authors:  Henrike C Besche; Andreas Peth; Alfred L Goldberg
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

9.  A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia.

Authors:  Qing Geng; Jacqueline Romero; Vikas Saini; Todd A Baker; Maria M Picken; Richard L Gamelli; Matthias Majetschak
Journal:  Biochem Biophys Res Commun       Date:  2009-12-25       Impact factor: 3.575

10.  Atrophy and hypertrophy signalling in the diaphragm of patients with COPD.

Authors:  D Testelmans; T Crul; K Maes; A Agten; M Crombach; M Decramer; G Gayan-Ramirez
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

View more
  64 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-κB pathway.

Authors:  Canguo Zhao; Shouting Liu; Changshan Yang; Xiaofen Li; Hongbiao Huang; Ningning Liu; Shujue Li; Xuejun Wang; Jinbao Liu
Journal:  Am J Cardiovasc Dis       Date:  2013-08-16

3.  Prolongation of myocardial viability by proteasome inhibition during hypothermic organ preservation.

Authors:  Todd A Baker; Qing Geng; Jacqueline Romero; Maria M Picken; Richard L Gamelli; Matthias Majetschak
Journal:  Biochem Biophys Res Commun       Date:  2010-09-26       Impact factor: 3.575

4.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Authors:  Jie Li; Saul R Powell; Xuejun Wang
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

5.  Age influences inflammatory responses, hemodynamics, and cardiac proteasome activation during acute lung injury.

Authors:  Helena M Linge; Ji Young Lee; Kanta Ochani; Kiyokazu Koga; Nina Kohn; Kaie Ojamaa; Saul R Powell; Edmund J Miller
Journal:  Exp Lung Res       Date:  2015-04-06       Impact factor: 2.459

Review 6.  Proteasome functional insufficiency in cardiac pathogenesis.

Authors:  Xuejun Wang; Jie Li; Hanqiao Zheng; Huabo Su; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

7.  Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation.

Authors:  Nicole C Goodwin; Giovanni Cianchetta; Hugh A Burgoon; Jason Healy; Ross Mabon; Eric D Strobel; Jason Allen; Shuli Wang; Brian D Hamman; David B Rawlins
Journal:  ACS Med Chem Lett       Date:  2014-08-07       Impact factor: 4.345

8.  A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.

Authors:  C Zhao; X Chen; D Zang; X Lan; S Liao; C Yang; P Zhang; J Wu; X Li; N Liu; Y Liao; H Huang; X Shi; L Jiang; X Liu; Z He; Q P Dou; X Wang; J Liu
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

9.  Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation.

Authors:  Xianping Shi; Xin Chen; Xiaofen Li; Xiaoying Lan; Chong Zhao; Shouting Liu; Hongbiao Huang; Ningning Liu; Siyan Liao; Wenbin Song; Ping Zhou; Shunqing Wang; Li Xu; Xuejun Wang; Q Ping Dou; Jinbao Liu
Journal:  Clin Cancer Res       Date:  2013-12-12       Impact factor: 12.531

Review 10.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.